Literature DB >> 19990873

The Endocrine Control of the Prostate: (Section of Urology).

S Zuckerman.   

Abstract

Year:  1936        PMID： 19990873      PMCID： PMC2076281     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  5 in total

1.  Comparative activities of compounds of the androsterone-testosterone series.

Authors:  R Deanesly; A S Parkes
Journal:  Biochem J       Date:  1936-02       Impact factor: 3.857

2.  The effect of oestrone on normal and castrated male rats.

Authors:  V Korenchevsky; M Dennison
Journal:  Biochem J       Date:  1934       Impact factor: 3.857

3.  Conditions of hypertrophy of the seminal vesicles in rats.

Authors:  J Freud
Journal:  Biochem J       Date:  1933       Impact factor: 3.857

4.  Effect of androsterone and of male hormone concentrates on the accessory reproductive organs of castrated rats, mice and guinea-pigs.

Authors:  R K Callow; R Deanesly
Journal:  Biochem J       Date:  1935-06       Impact factor: 3.857

5.  Conditions of hypertrophy of seminal vesicles in rats: The effect of derivatives of oestrone (menformon).

Authors:  K David; J Freud; S E De Jongh
Journal:  Biochem J       Date:  1934       Impact factor: 3.857
  5 in total
  12 in total

1.  The development of the utricle and of the so-called 'middle' or 'median' lobe of the human prostate.

Authors:  T W GLENISTER
Journal:  J Anat       Date:  1962-10       Impact factor: 2.610

2.  Prostatic Enlargement and its Treatment.

Authors:  K Walker
Journal:  Br Med J       Date:  1938-07-09

3.  Benign nodular hyperplasia of the prostate; a review.

Authors:  L M FRANKS
Journal:  Ann R Coll Surg Engl       Date:  1953-02       Impact factor: 1.891

Review 4.  Benign prostatic hyperplasia: a new metabolic disease?

Authors:  L Vignozzi; G Rastrelli; G Corona; M Gacci; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2014-01-24       Impact factor: 4.256

Review 5.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

6.  Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra.

Authors:  Barry G Timms; Kembra L Howdeshell; Lesley Barton; Sarahann Bradley; Catherine A Richter; Frederick S vom Saal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

7.  Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses.

Authors:  F S vom Saal; B G Timms; M M Montano; P Palanza; K A Thayer; S C Nagel; M D Dhar; V K Ganjam; S Parmigiani; W V Welshons
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 8.  The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.

Authors:  P T Scardino
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

9.  A morphological study of the prostatic lobes and the seminal vesicles of castrated rats injected with oestradiol and/or insulin.

Authors:  L E Tisell; H Andersson; L Angervall
Journal:  Urol Res       Date:  1976-07-23

10.  Fetal bisphenol A and ethinylestradiol exposure alters male rat urogenital tract morphology at birth: Confirmation of prior low-dose findings in CLARITY-BPA.

Authors:  Kristen S Uchtmann; Julia A Taylor; Barry G Timms; Richard W Stahlhut; Emily A Ricke; Mark R Ellersieck; Frederick S Vom Saal; William A Ricke
Journal:  Reprod Toxicol       Date:  2019-11-19       Impact factor: 3.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.